• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 94 of 100
These Fortune 500 companies leapfrogged the rest
FinanceThese Fortune 500 companies leapfrogged the rest
By Kia KokalitchevaJune 19, 2015
Flibanserin
FeaturesA female Viagra is one step closer to reality
By Laura LorenzettiJune 4, 2015
Food and Farm Livestock Antibiotics
RetailAntibiotics in meat: A public health controversy that isn’t going away
By Mark KobaJune 3, 2015
Bristol-Myers Squibb R&D headquarters
TechNew cancer drug combo shrinks tumors in 60% of patients – study
By TIME and Fortune EditorsJune 1, 2015
19 kids and cancelled: TV shows that got pulled due to controversy
Arts & Entertainment19 kids and cancelled: TV shows that got pulled due to controversy
By Daniel BukszpanMay 28, 2015
Can Gilead keep growing without a big deal?
FinanceCan Gilead keep growing without a big deal?
By Jen WiecznerMay 23, 2015
JPMorgan Chase & Co. CEO Jamie Dimon Speaks At An Institute Of International Finance Panel
FeaturesECB peps markets and JPMorgan shareholders vote on Dimon’s pay–5 things to know today
By Laura LorenzettiMay 19, 2015
157934085
FeaturesThe pharma M&A party is still in full swing, as Endo snaps up Par
By Geoffrey SmithMay 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
TechGlaxoSmithKline plans to work with U.S. scientists to develop a cure for AIDS
By ReutersMay 11, 2015
Biopharma deals are booming this year with no end in sight
FinanceBiopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
FeaturesCancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
By Laura LorenzettiMay 8, 2015
J&J brings in ethicists to judge on requests for experimental drugs
FeaturesJ&J brings in ethicists to judge on requests for experimental drugs
By ReutersMay 7, 2015
Inside of a Gilead Sciences Lab
TechDrugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By ReutersMay 6, 2015
Clashes in Baltimore over death of Freddie Gray
FeaturesBaltimore riots, Google, and Twitter earnings — 5 things to know today
By Laura LorenzettiApril 28, 2015
Ontario Closer Than Ever To Legalization Of Marijuana
LeadershipHow new blood in Washington, DC could impact the marijuana industry
By Tom Huddleston Jr.April 24, 2015
1...
  • 92
  • 93
  • 94
  • 95
  • 96
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.